Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Vilardell

Showing results (51-60 of 264) with videos related to

Pageof 27
Sort By:
Annals of Internal Medicine|February 1, 1986
Serum thrombocytopenia and high-dose immunoglobulin treatmentJ Ordi, M Vilardell, J Alijotas, et al.
Medicina Clinica|November 10, 1980
[Cryofibrinogen]F Garcia Bragado Dalmau, M Vilardell Tarres, V Fonollosa Pla
The American Journal of Medicine|March 1, 1988
Lupus anticoagulant and portal hypertensionJ Ordi, V Vargas, M Vilardell, et al.
Medicina Clinica|April 9, 1983
[Tuberculosis of the breast]M Vilardell, R Marquet, M de la Figuera, et al.
The Journal of Rheumatology|January 1, 1993
Prevalence of Raynaud's phenomenon in a healthy Spanish populationG Riera, M Vilardell, J Vaqué, et al.
Clinical and Experimental Immunology|October 14, 2016
DUSP23 is over-expressed and linked to the expression of DNMTs in CD4<sup>+</sup> T cells from systemic lupus erythematosus patientsE Balada, L Felip, J Ordi-Ros, et al.
Medicina Clinica|June 21, 1986
[Comparative study of beta 2-microglobulin and carcinoembryonic antigen in 93 cancer patients. Usefulness of the combined determination of both markers]J A Bosch, A Ruibal, M Vilardell, et al.
Revista Clinica Espanola|September 15, 1984
[Thrombopenia and carcinoma]R Parra, F García-Bragado, M Villar, et al.
International Journal of Immunogenetics|September 20, 2011
The PTPN22*R620W polymorphism does not confer genetic susceptibility to antiphospholipid syndrome in the Spanish populationJ Castro-Marrero, E Balada, M Vilardell-Tarrés, et al.
British Journal of Rheumatology|February 1, 1995
Skin hyper-reactivity in patients with benign intracranial hypertension as an early manifestation of Behçet's diseaseJ A Bosch, M Valdes, R Solans, et al.
Pageof 27

Showing results (51-60 of 264) with videos related to

Sort By:
Pageof 27
Annals of Internal Medicine|February 1, 1986
Serum thrombocytopenia and high-dose immunoglobulin treatmentJ Ordi, M Vilardell, J Alijotas, et al.
Medicina Clinica|November 10, 1980
[Cryofibrinogen]F Garcia Bragado Dalmau, M Vilardell Tarres, V Fonollosa Pla
The American Journal of Medicine|March 1, 1988
Lupus anticoagulant and portal hypertensionJ Ordi, V Vargas, M Vilardell, et al.
Medicina Clinica|April 9, 1983
[Tuberculosis of the breast]M Vilardell, R Marquet, M de la Figuera, et al.
The Journal of Rheumatology|January 1, 1993
Prevalence of Raynaud's phenomenon in a healthy Spanish populationG Riera, M Vilardell, J Vaqué, et al.
Clinical and Experimental Immunology|October 14, 2016
DUSP23 is over-expressed and linked to the expression of DNMTs in CD4<sup>+</sup> T cells from systemic lupus erythematosus patientsE Balada, L Felip, J Ordi-Ros, et al.
Medicina Clinica|June 21, 1986
[Comparative study of beta 2-microglobulin and carcinoembryonic antigen in 93 cancer patients. Usefulness of the combined determination of both markers]J A Bosch, A Ruibal, M Vilardell, et al.
Revista Clinica Espanola|September 15, 1984
[Thrombopenia and carcinoma]R Parra, F García-Bragado, M Villar, et al.
International Journal of Immunogenetics|September 20, 2011
The PTPN22*R620W polymorphism does not confer genetic susceptibility to antiphospholipid syndrome in the Spanish populationJ Castro-Marrero, E Balada, M Vilardell-Tarrés, et al.
British Journal of Rheumatology|February 1, 1995
Skin hyper-reactivity in patients with benign intracranial hypertension as an early manifestation of Behçet's diseaseJ A Bosch, M Valdes, R Solans, et al.
Pageof 27